# Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia

> **NCT00610623** · PHASE2 · TERMINATED · sponsor: **Anbics Management-Services Ag** · enrollment: 92 (actual)

## Conditions studied

- Pneumonia, Ventilator-Associated
- Pseudomonas Infections

## Interventions

- **DRUG:** azithromycin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00610623
- **Lead sponsor:** Anbics Management-Services Ag
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-04
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 92 (ACTUAL)
- **Why stopped:** The sponsor decided to stop the study prematurely because of financial issues
- **Last updated:** 2008-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610623, "Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00610623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*